Publications
Detailed Information
Administration of tauroursodeoxycholic acid enhances osteogenic differentiation of bone marrow-derived mesenchymal stem cells and bone regeneration
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cha, Byung-Hyun | - |
dc.contributor.author | Jung, Moon-Joo | - |
dc.contributor.author | Moon, Bo-Kyung | - |
dc.contributor.author | Kim, Jin-Su | - |
dc.contributor.author | Ma, Yoonji | - |
dc.contributor.author | Arai, Yoshie | - |
dc.contributor.author | Noh, Myungkyung | - |
dc.contributor.author | Shin, Jung-Youn | - |
dc.contributor.author | Kim, Byung-Soo | - |
dc.contributor.author | Lee, Soo-Hong | - |
dc.date.accessioned | 2024-06-13T02:13:27Z | - |
dc.date.available | 2024-06-13T02:13:27Z | - |
dc.date.created | 2018-06-19 | - |
dc.date.created | 2018-06-19 | - |
dc.date.created | 2018-06-19 | - |
dc.date.issued | 2016-02 | - |
dc.identifier.citation | Bone, Vol.83, pp.73-81 | - |
dc.identifier.issn | 8756-3282 | - |
dc.identifier.uri | https://hdl.handle.net/10371/204273 | - |
dc.description.abstract | It is known that osteogenic differentiation of mesenchymal stem cells (MSCs) can be promoted by suppression of adipogenesis of MSCs. We have recently found that the chemical chaperone tauroursodeoxycholic acid (TUDCA) significantly reduces adipogenesis of MSCs. In the present study, we examined whether TUDCA can promote osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMMSCs) by regulating Integrin 5 (ITGA5) associated with activation of ERK1/2 signal pathway and thereby enhance bone tissue regeneration by reducing apoptosis and the inflammatory response. TUDCA treatment promoted in vitro osteogenic differentiation of BMMSCs and in vivo bone tissue regeneration in a calvarial defect model, as confirmed by micro computed tomography, histological staining, and immunohistochemistry for osteocalcin. In addition, TUDCA treatment significantly decreased apoptosis and the inflammatory response in vivo and in vitro, which is important to enhance bone tissue regeneration. These results indicate that TUDCA plays a critical role in enhancing osteogenesis of BMMSCs, and is therefore a potential alternative drug for bone tissue regeneration. (c) 2015 Elsevier Inc. All rights reserved. | - |
dc.language | 영어 | - |
dc.publisher | Elsevier BV | - |
dc.title | Administration of tauroursodeoxycholic acid enhances osteogenic differentiation of bone marrow-derived mesenchymal stem cells and bone regeneration | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bone.2015.10.011 | - |
dc.citation.journaltitle | Bone | - |
dc.identifier.wosid | 000368571000009 | - |
dc.identifier.scopusid | 2-s2.0-84945926065 | - |
dc.citation.endpage | 81 | - |
dc.citation.startpage | 73 | - |
dc.citation.volume | 83 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Kim, Byung-Soo | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | ENDOPLASMIC-RETICULUM STRESS | - |
dc.subject.keywordPlus | CYTOCHROME-C RELEASE | - |
dc.subject.keywordPlus | MORPHOGENETIC PROTEIN-2 | - |
dc.subject.keywordPlus | SMALL-MOLECULE | - |
dc.subject.keywordPlus | STROMAL CELLS | - |
dc.subject.keywordPlus | OSTEOBLAST DIFFERENTIATION | - |
dc.subject.keywordPlus | SURFACE MODIFICATION | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR | - |
dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
dc.subject.keywordPlus | GROWTH-FACTORS | - |
dc.subject.keywordAuthor | Tauroursodeoxycholic acid | - |
dc.subject.keywordAuthor | Mesenchymal stem cells | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Inflammatory | - |
dc.subject.keywordAuthor | Osteogenic differentiation | - |
dc.subject.keywordAuthor | Bone tissue regeneration | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.